NOTCH1 and anaplastic large cell lymphoma: Additionally, γ-secretase inhibitors suppressed the proliferation of ALK+ ALCL cells with crizotinib resistance, suggesting NOTCH1 as a therapeutic target in crizotinib-resistant ALK+ ALCL (124, 125).